Michael Arenberg

This profile gathers the share dealings of Michael Arenberg across 2 companies, led by Imago BioSciences, Inc. and Durect Corp. In total, 8 filings cover trades dated from 12 March 2019 to 11 January 2023.

On the open market, the record shows 1 purchase worth €7,096 and 2 sales worth €4.0M. Sales outweigh purchases by €4.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 option exercises.

Most recently, on 11 January 2023, the filings show a transaction worth €1.7M in Imago BioSciences, Inc. The last purchase on record was published on 13 March 2019, which is 2,782 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.